KOHJIN BIO CO LTD (177A.T)
JPY 1703.0
(-0.12%)
JPY 1703.0
(-0.12%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 958.1 Million JPY | -33.67% |
| 2022 | 1.44 Billion JPY | 27.17% |
| 2021 | 1.14 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 FY | - JPY | -33.67% |
| 2023 Q4 | 244.02 Million JPY | 0.0% |
| 2022 FY | - JPY | 27.17% |
| 2021 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PRISM BioLab Co.,LTD | -488.13 Million JPY | 296.279% |
| GNI Group Ltd. | 14.48 Billion JPY | 93.387% |
| Linical Co., Ltd. | 1.24 Billion JPY | 23.182% |
| Trans Genic Inc. | 240.95 Million JPY | -297.632% |
| MEDINET Co., Ltd. | -1.35 Billion JPY | 170.664% |
| Soiken Holdings Inc. | -583.2 Million JPY | 264.282% |
| Cytori Cell Research Institute, Inc. | -603.09 Million JPY | 258.865% |
| AnGes, Inc. | -8.86 Billion JPY | 110.814% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 174.532% |
| Nxera Pharma Co., Ltd. | -7.39 Billion JPY | 112.949% |
| Immuno-Biological Laboratories Co., Ltd. | 128.1 Million JPY | -647.892% |
| NanoCarrier Co., Ltd. | -863 Million JPY | 211.02% |
| Carna Biosciences, Inc. | -1.09 Billion JPY | 187.756% |
| CanBas Co., Ltd. | 53.65 Million JPY | -1685.805% |
| D. Western Therapeutics Institute, Inc. | -775.59 Million JPY | 223.532% |
| RaQualia Pharma Inc. | -111.8 Million JPY | 956.971% |
| Chiome Bioscience Inc. | -1.21 Billion JPY | 179.068% |
| Kidswell Bio Corporation | -1.38 Billion JPY | 169.386% |
| PeptiDream Inc. | 7.37 Billion JPY | 87.011% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 149.651% |
| Ribomic Inc. | -1.01 Billion JPY | 194.625% |
| SanBio Company Limited | -4.52 Billion JPY | 121.174% |
| Healios K.K. | -3 Billion JPY | 131.862% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 182.185% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 168.776% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 168.338% |
| StemRIM | -2.03 Billion JPY | 147.151% |
| CellSource Co., Ltd. | 1.3 Billion JPY | 26.663% |
| FunPep Company Limited | -952 Million JPY | 200.641% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 207.802% |
| Stella Pharma Corporation | -723.85 Million JPY | 232.361% |
| TMS Co., Ltd. | -937 Million JPY | 202.252% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 223.564% |
| Cuorips Inc. | -518 Million JPY | 284.962% |
| K Pharma,Inc. | 366.05 Million JPY | -161.735% |
| Takara Bio Inc. | 8.02 Billion JPY | 88.06% |
| ReproCELL Incorporated | 8.24 Million JPY | -11520.4% |
| PhoenixBio Co., Ltd. | 87.93 Million JPY | -989.52% |
| StemCell Institute Inc. | 534.35 Million JPY | -79.301% |
| Japan Tissue Engineering Co., Ltd. | 244.81 Million JPY | -291.359% |
| CellSeed Inc. | -836.51 Million JPY | 214.535% |